Health & Safety Industry Today
Laboratory Automation Systems and Processes Market to Reach $17.56 Billion by 2034 from $8.68 Billion in 2025 - SRI
London, UK - June 2026 | Strategic Revenue Insights Inc. –The laboratory automation systems and processes market is expanding at a strong pace, driven by rising demand for high-throughput screening, increasing focus on laboratory workflow efficiency, and accelerating adoption of AI-powered automation platforms across pharmaceutical, biotech, clinical, and research environments. Automation systems are transforming laboratory operations by reducing human error, improving data reproducibility, and enabling scientists to process higher sample volumes with greater precision and consistency.
The market spans four primary offering categories including automation systems, automated workcells, process software, and integration services. These solutions serve pharmaceutical and biotech companies, clinical laboratories, academic and research institutes, and contract research organizations across standalone, modular, and fully integrated automation levels, addressing a wide spectrum of laboratory complexity and throughput requirements globally.
A comprehensive assessment of this rapidly evolving market can be accessed through Strategic Revenue Insights at the link below, focused on Laboratory Automation Systems and Processes:
https://www.strategicrevenueinsights.com/industry/laboratory-automation-systems-and-processes-market
The global pharmaceutical and biotechnology industry's intensifying focus on drug discovery, personalized medicine, and genomic research is the primary structural driver of laboratory automation demand. As drug development pipelines expand and clinical trial complexity increases, pharmaceutical and biotech companies require automated laboratory systems capable of processing thousands of samples rapidly and accurately. Companies including Thermo Fisher Scientific, Danaher, and Roche are developing increasingly sophisticated automation platforms that directly address these high-throughput, high-accuracy requirements across the drug discovery and development lifecycle.
Energy and resource efficiency in laboratory operations is becoming a strategic priority as organizations seek to reduce operational costs and environmental impact. Automated liquid handling and sample management systems consume significantly less reagent volume per assay than manual processes, reducing material costs and waste generation. Workflow orchestration platforms optimize instrument scheduling and resource utilization across connected laboratory equipment, delivering measurable operational efficiency gains that justify automation investment across both large pharmaceutical facilities and smaller clinical laboratory environments.
Browse the associated report:
The integration of artificial intelligence, machine learning, and cloud-based laboratory informatics platforms is fundamentally reshaping laboratory automation capabilities. AI-powered image analysis, predictive instrument maintenance, and automated data quality assessment are enabling laboratories to extract deeper insights from experimental data while reducing manual review workloads. Cloud connectivity allows remote monitoring, cross-site data sharing, and real-time workflow visibility, accelerating the shift toward fully digitalized laboratory operations. These digital intelligence capabilities are a primary competitive differentiator among leading automation platform providers including Agilent Technologies, Tecan Group, and PerkinElmer.
Offering segmentation covers automation systems, automated workcells, process software, and integration services. Automation systems represent the largest revenue category, anchored by high-value capital equipment procurement from pharmaceutical and biotech customers. Automated workcells are growing rapidly, offering flexible and scalable automation configurations that can be customized to specific assay workflows. Process software and integration services are the fastest-growing offering segments, driven by laboratory digitalization initiatives and the increasing complexity of multi-instrument automation environments requiring seamless system coordination.
Get a Free Sample Copy of this Report and you can Buy Now Directly @
Application segmentation spans sample preparation, liquid handling, storage and retrieval, assay automation, and workflow orchestration. Sample preparation and liquid handling are the dominant application categories, forming the operational foundation of most automated laboratory workflows. Assay automation is a high-growth application area, driven by the expansion of high-throughput drug screening programs and clinical diagnostic testing volumes. Workflow orchestration is an emerging and strategically important application segment, enabling intelligent coordination of automated processes across entire laboratory ecosystems rather than individual instrument stations.
Automation level segmentation includes standalone, modular, and fully integrated systems. Standalone systems serve laboratories requiring automation of specific individual processes without full workflow integration. Modular systems are gaining strong adoption among mid-sized pharmaceutical and clinical laboratory operations seeking scalable automation architectures that can expand incrementally with changing throughput demands. Fully integrated systems represent the highest-value segment, enabling end-to-end laboratory automation from sample receipt through result reporting, serving large-scale pharmaceutical research facilities and high-volume clinical testing laboratories.
High initial capital investment requirements for laboratory automation systems remain a significant adoption barrier, particularly for smaller academic institutions, independent clinical laboratories, and emerging market healthcare facilities with constrained procurement budgets. The need for specialized technical expertise to implement, validate, and maintain automation systems creates ongoing operational cost pressures and talent acquisition challenges. Regulatory compliance requirements for automated systems used in clinical and pharmaceutical quality control contexts add validation burden and documentation overhead that can slow implementation timelines and increase total cost of ownership.
Related Report:
Tablet Coating Machine Market – https://www.strategicrevenueinsights.com/industry/tablet-coating-machine-market
Predictive Analytics Solutions For Pcr Resin Quality Market – https://www.strategicrevenueinsights.com/industry/predictive-analytics-solutions-for-pcr-resin-quality-market
Electronic Expansion Valves Market – https://www.strategicrevenueinsights.com/industry/electronic-expansion-valves-market
Tissue Protectors Market – https://www.strategicrevenueinsights.com/industry/tissue-protectors-market
Autism Diagnostics Market – https://www.strategicrevenueinsights.com/industry/autism-diagnostics-market
The United States is the largest national market, valued at approximately $4.5 billion with a CAGR of 7%, driven by a dense concentration of pharmaceutical and biotech companies, world-leading research institutions, and high technology adoption rates. Germany, at around $1.2 billion with a CAGR of 6%, benefits from its strong pharmaceutical manufacturing base and the presence of global leaders including Siemens Healthineers and Roche. China is a high-growth market at approximately $1 billion with a CAGR of 10%, driven by expanding healthcare infrastructure investment and government support for life sciences research. India, at around $800 million with a CAGR of 12%, is the fastest-growing national market, supported by a rapidly expanding pharmaceutical manufacturing sector and increasing drug discovery investment. Brazil grows at approximately $600 million with a CAGR of 8%, underpinned by growing healthcare expenditure and expanding clinical laboratory capacity.
The competitive landscape includes Thermo Fisher Scientific, Danaher, Agilent Technologies, Tecan Group, PerkinElmer, Hamilton Company, Siemens Healthineers, Beckman Coulter, Roche, and Eppendorf. Thermo Fisher Scientific leads through its comprehensive automation portfolio and global commercial infrastructure. Danaher has strengthened its position through the Beckman Coulter acquisition, creating an integrated clinical and research automation platform. Tecan Group is recognized for innovative liquid handling and workcell solutions, while PerkinElmer expanded its capabilities through the BioLegend acquisition. Hamilton Company maintains a strong position in precision liquid handling automation serving pharmaceutical and genomics laboratories.
The laboratory automation systems and processes market is positioned for sustained, strong growth through 2034, driven by pharmaceutical industry expansion, personalized medicine advancement, and accelerating laboratory digitalization. Companies investing in AI-enhanced automation intelligence, modular scalable architectures, and cloud-connected workflow management platforms will be best positioned to capture long-term market leadership in this strategically vital life sciences infrastructure segment.
About Strategic Revenue Insights Inc.
Strategic Revenue Insights Inc., a distinguished subsidiary of SRI Consulting Group Ltd, stands as a premier provider of data-driven market intelligence, empowering organizations globally to navigate complex business landscapes with confidence and precision. Headquartered in London, United Kingdom, our firm specializes in delivering comprehensive syndicated research reports, bespoke consulting solutions, and actionable strategic insights that enable clients to make informed, forward-thinking decisions in an increasingly competitive marketplace.
Our dedicated team of accomplished analysts, strategically positioned in London with an extensive global network, maintains continuous vigilance over evolving market dynamics, identifying emerging trends and uncovering high-potential growth opportunities that drive sustained client success. As an integral component of SRI Consulting Group Ltd, we uphold unwavering commitments to analytical accuracy, clarity of presentation, and practical applicability, assisting organizations in navigating competitive terrain, optimizing strategic initiatives, and accelerating revenue trajectories.
Through the integration of rigorous research methodologies with profound industry expertise, Strategic Revenue Insights Inc. delivers comprehensive market perspectives that generate measurable outcomes and establish enduring competitive advantages for our clients across diverse sectors and geographies.
Media Contact Information
Company Name: Strategic Revenue Insights Inc.
Contact Person: Rohit Bhisey
Email: sales@strategicrevenueinsights.com
Phone: +44 7877403352
Address: Suite 10, Capital House, 61 Amhurst Road, E8 1LL
City: London
State: London
Country: United Kingdom
Corporate Websites:
www.strategicrevenueinsights.com
www.strategicpackaginginsights.com
https://strategicrevenueinsights.blog/
https://medium.com/@strategic-revenue-insights.inc
For partnership inquiries, custom research requests, or detailed market analysis consultations, we invite you to connect with our team of experts who are committed to delivering strategic intelligence that transforms business outcomes.
Share on Social Media
Contact Information
Rohit Bhisey
Strategic Revenue Insights Inc.
Suite10 Capital House 61 Amhurst Road,
London
London
United kingdom
E8 1LL
+44-787-740-3352
https://www.strategicrevenueinsights.com/
Other Industry News
Ready to start publishing
Sign Up today!
